• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Sarcopenia Is a Condition With Increasing Importance in Medical Oncology.肌肉减少症在医学肿瘤学中的重要性日益增加。
Oncologist. 2016 Feb;21(2):e1. doi: 10.1634/theoncologist.2015-0431. Epub 2016 Jan 14.
2
In Reply.作为回复。
Oncologist. 2016 Feb;21(2):e2. doi: 10.1634/theoncologist.2015-0465. Epub 2016 Jan 14.
3
Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.营养状况、体表面积以及低瘦体重/体重指数与非小细胞肺癌患者中阿法替尼引起的剂量减少和严重胃肠道毒性相关。
Oncologist. 2015 Aug;20(8):967-74. doi: 10.1634/theoncologist.2015-0058. Epub 2015 Jul 14.
4
Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: results from a prospective feasibility study.
Lung Cancer. 2005 Dec;50(3):413-5. doi: 10.1016/j.lungcan.2005.07.006. Epub 2005 Sep 8.
5
[Non-small cell lung cancer: 2) Epidermal growth factor receptor inhibitor and severe adverse phenomena].
Nihon Naika Gakkai Zasshi. 2003 Jul 10;92(7):1291-5.
6
Interstitial lung disease and gefitinib.
N Engl J Med. 2010 Oct 14;363(16):1579; author reply 1579-80. doi: 10.1056/NEJMc1008506.
7
The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGFR inhibitors.SERIES诊所：一种管理表皮生长因子受体抑制剂毒性的跨学科方法。
J Support Oncol. 2006 May;4(5):236-8.
8
Erlotinib or gefitinib for non-small-cell lung cancer.厄洛替尼或吉非替尼用于治疗非小细胞肺癌。
N Engl J Med. 2011 Jun 16;364(24):2367; author reply 2368. doi: 10.1056/NEJMc1103918.
9
Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) ).
Int J Dermatol. 2014 Mar;53(3):e190-2. doi: 10.1111/j.1365-4632.2012.05780.x. Epub 2013 May 15.
10
Interstitial lung disease and gefitinib.
N Engl J Med. 2010 Oct 14;363(16):1578-9; author reply 1579-80. doi: 10.1056/NEJMc1008506.

引用本文的文献

1
Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning.利用骨骼肌 CT 放射组学和机器学习识别晚期非小细胞肺癌患者的肌肉减少症。
Thorac Cancer. 2020 Sep;11(9):2650-2659. doi: 10.1111/1759-7714.13598. Epub 2020 Aug 6.
2
Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial.索拉非尼或安慰剂治疗放射性碘难治性晚期分化型甲状腺癌患者的身体成分：III 期 DECISION 试验的回顾性分析。
Thyroid. 2019 Dec;29(12):1820-1827. doi: 10.1089/thy.2018.0784.
3
In Reply.作为回复。
Oncologist. 2016 Feb;21(2):e2. doi: 10.1634/theoncologist.2015-0465. Epub 2016 Jan 14.

本文引用的文献

1
Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.营养状况、体表面积以及低瘦体重/体重指数与非小细胞肺癌患者中阿法替尼引起的剂量减少和严重胃肠道毒性相关。
Oncologist. 2015 Aug;20(8):967-74. doi: 10.1634/theoncologist.2015-0058. Epub 2015 Jul 14.
2
Sarcopenia is more than simply documenting low skeletal muscle mass.肌肉减少症不仅仅是记录低骨骼肌质量。
Cancer. 2015 Jan 1;121(1):159. doi: 10.1002/cncr.29016. Epub 2014 Sep 10.
3
Body composition and outcome in patients undergoing resection of colorectal liver metastases.结直肠肝转移瘤切除术后患者的体成分与预后。
Br J Surg. 2012 Apr;99(4):550-7. doi: 10.1002/bjs.7823. Epub 2012 Jan 13.
4
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.肌肉减少症：欧洲定义和诊断共识：老年人肌肉减少症欧洲工作组报告。
Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.

肌肉减少症在医学肿瘤学中的重要性日益增加。

Sarcopenia Is a Condition With Increasing Importance in Medical Oncology.

作者信息

Cintosun Umit, Altun Battal, Tasci Ilker

机构信息

Department of Geriatrics, Gulhane School of Medicine, Ankara, Turkey.

Department of Internal Medicine, Kasımpasa Military Hospital, Istanbul, Turkey.

出版信息

Oncologist. 2016 Feb;21(2):e1. doi: 10.1634/theoncologist.2015-0431. Epub 2016 Jan 14.

DOI:10.1634/theoncologist.2015-0431
PMID:26768481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4746095/
Abstract

A recent study reported that routinely screening for sarcopenia and nutritional status was helpful in determining toxicity and treatment in patients with non-small cell lung cancer. Although a decrease in muscle mass was detected in 68.8% of the participants, it is not evident what proportion the patients had true sarcopenia. Clarification of these issues may be relevant to the study results.

摘要

最近一项研究报告称，对肌肉减少症和营养状况进行常规筛查有助于确定非小细胞肺癌患者的毒性和治疗方案。虽然在68.8%的参与者中检测到肌肉量减少，但尚不清楚患者中真正患有肌肉减少症的比例是多少。澄清这些问题可能与研究结果相关。